Transient hypertransaminasemia in paediatric patients with Crohn disease undergoing initial treatment with enteral

Ellen Schatorjé1, Hans Hoekstra

  • 1Department of Pediatrics, Hieronymus Bosch Hospital, Hertogenbosch, The Netherlands.

Insights

Total enteral nutrition (TEN) in children with Crohn disease can cause temporary liver enzyme elevations. This transient hypertransaminasemia is linked to insulin resistance and hepatic steatosis, not actual liver disease.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Inflammatory Bowel Disease Research

Background:

  • Total enteral nutrition (TEN) is a common monotherapy for pediatric Crohn disease, often used to mitigate steroid toxicity.
  • Liver disease is a recognized complication in inflammatory bowel disease, necessitating regular monitoring of liver enzymes in affected children.

Purpose of the Study:

  • To prospectively evaluate the impact of TEN on liver enzyme levels in pediatric Crohn disease patients.
  • To determine the incidence and pattern of liver enzyme changes during TEN therapy and assess for actual liver disease development.

Main Methods:

  • Prospective follow-up of 11 pediatric patients (ages 7.6-17.1 years) treated with TEN for 6 weeks.
  • Measurement of liver enzymes (ASAT, ALAT, GGT, alkaline phosphatase, bilirubin) at baseline, and at 3, 6, and 12 weeks during and after TEN therapy.

Main Results:

  • Transient elevations in aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT) were observed in 9 and 10 out of 11 patients, respectively.
  • Peak elevations occurred at 3 weeks of TEN, with values significantly decreasing by 6 and 12 weeks.
  • No patients developed clinically evident liver disease, and 9 achieved prolonged clinical remission.

Conclusions:

  • TEN therapy in children with Crohn disease is associated with transient hypertransaminasemia, likely due to insulin resistance and hepatic steatosis.
  • This elevation in liver enzymes is a benign, transient condition and not indicative of underlying liver disease.
  • Clinicians should be aware of this TEN-associated phenomenon to avoid unnecessary investigations and ensure appropriate patient management.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...